UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000035922 |
|---|---|
| Receipt number | R000040906 |
| Scientific Title | Analytical study of carbohydrate structure change of urological disease |
| Date of disclosure of the study information | 2019/02/18 |
| Last modified on | 2022/07/31 15:41:24 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Analytical study of carbohydrate structure change of urological disease
Acronym
Analytical study of carbohydrate structure change of urological disease
Scientific Title
Analytical study of carbohydrate structure change of urological disease
Scientific Title:Acronym
Analytical study of carbohydrate structure change of urological disease
Region
| Japan |
Condition
Condition
urological disease
Classification by specialty
| Urology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To identify the carbohydrate structure which is a risk factor of development and progress of urological disease
Basic objectives2
Others
Basic objectives -Others
To identify the characteristics of carbohydrate structure of specimens of urinary diseases (blood, urine)
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Identification of carbohydrate structure which is a risk factor for onset and progress of urological disease
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| 100 | years-old | > |
Gender
Male and Female
Key inclusion criteria
Those who have urological disease understand the purpose of research and can agree
Key exclusion criteria
Person not grown up
Those who can not agree to research
Target sample size
500
Research contact person
Name of lead principal investigator
| 1st name | Makoto |
| Middle name | |
| Last name | Sato |
Organization
Tohoku Medical and Pharmaceutical University
Division name
Department of Urology
Zip code
9838536
Address
1-15-1 Fukumuro, MIyagino-ku, Sendai, Miyagi, JAPAN
TEL
0222591221
ms.hifu@tohoku-mpu.ac.jp
Public contact
Name of contact person
| 1st name | Go |
| Middle name | |
| Last name | Anan |
Organization
Tohoku Medical and Pharmaceutical University
Division name
Department of Urology
Zip code
983-8536
Address
1-15-1 Fukumuro, MIyagino-ku, Sendai, Miyagi, JAPAN
TEL
0222591221
Homepage URL
goanan@tohoku-mpu.ac.jp
Sponsor or person
Institute
Tohoku Medical and Pharmaceutical University
Institute
Department
Personal name
Funding Source
Organization
Self funding
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Tohoku Medical and Pharmaceutical University
Address
1-15-1 Fukumuro, MIyagino-ku, Sendai, Miyagi, JAPAN
Tel
0222591221
tikenn@hosp.tohoku-mpu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2019 | Year | 02 | Month | 18 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
300
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2018 | Year | 03 | Month | 23 | Day |
Date of IRB
| 2018 | Year | 03 | Month | 23 | Day |
Anticipated trial start date
| 2018 | Year | 03 | Month | 23 | Day |
Last follow-up date
| 2022 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
It aims to retrieve the glycosylation structure which is a risk factor of the onset and progress of urological disease and to use it for prevention of diseases and determination of treatment plan
Management information
Registered date
| 2019 | Year | 02 | Month | 18 | Day |
Last modified on
| 2022 | Year | 07 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040906
| Research Plan | |
|---|---|
| Registered date | File name |
| Research case data specifications | |
|---|---|
| Registered date | File name |
| Research case data | |
|---|---|
| Registered date | File name |
